Abstract
Bosutinib in Newly Diagnosed Chronic Myeloid Leukemia (CML): Gastrointestinal (GI), Liver, and Hematological Safety Characterization in the BFORE Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have